share_log

港股异动 | 医渡科技(02158)涨超7% 联合中山六院打造首个结直肠癌专科大模型 近期与腾讯达成战略合作

Hong Kong stocks flash | Yidu Technology (02158) rose more than 7%, working with Zhongshan Sixth Hospital to create the first large-scale model of colorectal cancer, recently reached a global strategic cooperation with Tencent.

Zhitong Finance ·  Sep 27 11:28

Yidu Technology (02158) rose more than 7%, as of the time of publication, it rose by 7.67%, closing at HKD 3.51, with a turnover of 17.873 million Hong Kong dollars.

According to the Wisdom Finance APP, Yidu Technology (02158) rose more than 7%, as of the time of publication, it rose by 7.67%, closing at HKD 3.51, with a turnover of 17.873 million Hong Kong dollars.

On the news front, recently Yidu Technology announced a joint effort with Sun Yat-sen University Affiliated Sixth Hospital (Sun Yat-sen Sixth Hospital) to create the first large-scale model of colorectal cancer specialty, aiming to improve the standardization of medical services through high-tech means, benefiting more patients. Yidu Technology stated that it is actively cooperating with several well-known tertiary hospitals including Sun Yat-sen Sixth Hospital to explore the field of specialty large-scale models, covering multiple specialty areas such as diabetes, orthodontics, cardiology, nasopharyngeal cancer, liver cancer, and more.

Additionally, the 2024 Tencent Global Digital Ecology Conference was successfully held recently. At the "Smart Medical" session, Yidu Technology and Tencent held a strategic cooperation signing ceremony. According to the agreement, both parties will leverage their respective strengths to deepen cooperation in infrastructure digital construction, operational management digital construction, and medical health business digitalization, jointly promoting the high-quality development of the digital medical system, and seeking new developments in the medical health industry in the AI era.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment